Get to know the MedRing

The MedRing Platform

Device

MedRing

A self-insertable and removable medical device to be placed into the vagina up to 28 days, to release precise doses of medication according to a personalized delivery schedule. The device can monitor bio signals and collect data to improve the treatment.

  • Shape and dimensions optimized for the vagina
  • Flexible materials for self-insertion and removal
  • Drug delivery
    • Pump for accurate drug administration
    • Suitable for a range of Active Pharmaceutical Ingredients (API)
    • Vaginal route: high bio-availability and no hepatic first-pass-effect
  • Operational lifetime of 28 days
  • Temperature measurement (for compliance)
  • Bluetooth connection

Smartphone

Companion App

The MedRing device is connected to the smartphone of the user via Bluetooth. Enabling control through the Companion App without removing the device.

The Companion App provides the status of the device, gives insight into the treatment progress and allows the personalization of the drug delivery schedule.

  • MedRing device activation
  • Communication with the MedRing via Bluetooth
  • Schedule time and dose of drug administration 
  • Collect device data and track treatment progress
  • In-app support and use instructions
  • Account authentication and secure login
  • Compatible with iOS & Android

Cloud

Data Platform

The cloud environment receives data from the Companion App to back-up personal settings, device configuration and treatment data.

  • Account administration
  • Authentication of users and devices
  • Secure transfer and storage of data
  • Data analysis for research and development
Future

Advanced Scheduling

The flexibility in drug administration scheduling offered by the MedRing provides numerous possibilities for advanced treatment.

  • Precise titration schedules
  • Tapering and chronotherapy
  • Drug delivery based on bio signals (closed-loop system)
Future

Diagnostic Opportunities

The continuous monitoring opportunity of the MedRing in the vaginal environment offers unique possibilities and allows for potential diagnostics.

  • Discrete 24/7 monitoring
  • Long-term remote monitoring
  • Treatment effectiveness feedback
  • Disease diagnostics
  • Platform for wide variety of sensors
Future

Digital Healthcare

The digitalization of drug administration and advanced monitoring provide, with consent of the patient, unprecedented data for the pharmaceutical and medical device industry.

  • Medication intake compliance
  • Aggregation of healthcare data
  • Exchange of data between healthcare systems
  • Advanced insights for pharmaceutical and clinical research

Get in touch

Office
Leiden Bio Science Park – BioPartner 1

Address
J.H. Oortweg 21
2333 CH Leiden
The Netherlands

Menu

Home
Product
Science
Company
News
Contact
Edit Template
Disclaimer policy
Privacy & Cookies
Edit Template